Angelalign Technology (HKSE:06699) ROCE % : 1.25% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Angelalign Technology's annualized ROCE % for the quarter that ended in Jun. 2024 was 1.25%.

Angelalign Technology ROCE % Historical Data

The historical data trend for Angelalign Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology ROCE % Chart

Angelalign Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

28.09

43.10

16.84

6.78

1.81

Angelalign Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial						4.71	9.23	1.91	1.69	1.25

Angelalign Technology ROCE % Calculation

Angelalign Technology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	75.662	/	( ( (5009.816 - 872.701)	+	(5202.728 - 961.54) )	/ 2 )
	=	75.662	/	( (4137.115	+	4241.188)	/ 2 )
	=	75.662	/	4189.1515
	=	1.81 %

Angelalign Technology's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	51.762	/	( ( (5202.728 - 961.54)	+	(5484.388 - 1451.996) )	/ 2 )
	=	51.762	/	( ( 4241.188	+	4032.392 )	/ 2 )
	=	51.762	/	4136.79
	=	1.25 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Angelalign Technology (HKSE:06699) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Angelalign Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Angelalign Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

AGLFF:USA

Address

No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN

Website

https://www.angelalign.com

Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Carecapital Ea, Inc	2201 Interest of corporation controlled by you
Carecapital Management Group Llc	2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited	2201 Interest of corporation controlled by you
Feng Dai	2201 Interest of corporation controlled by you
Shore Lead Limited	2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited	2101 Beneficial owner
Li Huamin	2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited	2101 Beneficial owner
Chen Kai	2201 Interest of corporation controlled by you
Jovial Day Global Limited	2201 Interest of corporation controlled by you
Vast Luck Global Limited	2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si	2102 Investment manager

Angelalign Technology Headlines

No Headlines